PMA device
Nit-Occlud Pda
Pfm Medical, Inc. · Occluder, Patent Ductus, Arteriosus (MAE, Class III) · First FDA decision Aug 16, 2013, newest Oct 17, 2024Congenital heart disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
3
Naming "Nit-Occlud Pda"
MAUDE reports
15
Brand "Nit-Occlud Pda", since 2015
PubMed studies
14
Mentioning "Nit-Occlud Pda"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Nit-Occlud Pda
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- NIT-OCCLUD PDAPMA supplement
P120009-S004 · Decided Oct 17, 2024 · 644 days after receipt · Normal 180 Day Track No User Fee
Device type: OCCLUDER, PATENT DUCTUS, ARTERIOSUS (MAE) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Nit-Occlud Pda", any status and sponsor, newest update first.
- Nit-Occlud PDA Post-Approval StudyCompleted
PFM Medical, IncNot on our public-company list
NCT02100683 · 184 participants · Start Aug 2014 · Primary completion Nov 20, 2019
Device: PDA Coil · For: Patent Ductus Arteriosus (PDA)
Sites: Loma Linda, California; Los Angeles, California; Madera, California · 11 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Nit-Occlud Pda", and for the whole product code for context.
This brand
15 reports: 13 malfunction, 2 injury, 0 death
Whole product code MAE
989 reports: 371 malfunction, 557 injury, 61 death
Newest reports for this brand
- NIT-OCCLUD PDAMalfunction
3005704822-2023-00001 · Received Mar 7, 2023 · Event dated Nov 9, 2022
Device type: Occluder, Patent Ductus, Arteriosus (MAE)
Device problem as coded: Device Dislodged or Dislocated; Premature Separation
Patient problem as coded: Failure of Implant
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Nit-Occlud Pda"[tiab]. The summary above synthesizes these.
- Transvenous closure of patent ductus arteriosus with Nit-Occlud® PDA occlusion system in 13 dogs weighing less than 3 kg.
Cala A, Ferasin L, Ferasin H, et al. · J Vet Cardiol · 2024
- Multicenter nit-occlud® PDA-R patent. Ductus arteriosus occlusion device trial: initial and six-month results.
Granja MA, Trentacoste L, Rivarola M, et al. · Catheter Cardiovasc Interv · 2015Multicenter Study, Observational Study
- Initial experience using NIT-OCCLUD® PDA-R device for percutaneous patent ductus arteriosus closure in Panama.
Campos-Quintero A, Lalire AL, Morales L, et al. · Arch Cardiol Mex · 2024
- Implantation of the new Nit-Occlud PDA-R device in children below 10 kilogram.
Moysich A, Happel CM, Laser KT, et al. · Catheter Cardiovasc Interv · 2015
- Techniques for trans-catheter retrieval of embolized Nit-Occlud® PDA-R and ASD-R devices.
Sinha S, Levi D, Peirone A, et al. · Catheter Cardiovasc Interv · 2018
- Results of the combined U.S. multicenter postapproval study of the Nit-Occlud PDA device for percutaneous closure of patent ductus arteriosus.
Kobayashi D, Salem MM, Forbes TJ, et al. · Catheter Cardiovasc Interv · 2019Comparative Study, Multicenter Study
- Immediate angiographic residual shunt using the Nit-Occlud device for patent ductus arteriosus closure.
Hiremath G, Aggarwal V, Soule K, et al. · Postepy Kardiol Interwencyjnej · 2020
- Closure of aortopulmonary window using Nit-Occlud® PDA-R device in a 3-month-old infant.
Odemis E, Guvenc O, Saygi M, et al. · Pediatr Int · 2016Case Reports
- Percutaneous closure of patent ductus arteriosus with the Nit-Occlud® patent ductus arteriosus device in 268 consecutive cases.
Maksymenko AV, Kuzmenko YL, Dovhaliuk AA, et al. · Ann Pediatr Cardiol · 2019
- Results of the combined U.S. Multicenter Pivotal Study and the Continuing Access Study of the Nit-Occlud PDA device for percutaneous closure of patent ductus arteriosus.
Moore JW, Greene J, Palomares S, et al. · JACC Cardiovasc Interv · 2014Clinical Trial, Multicenter Study
- Chronic hypobaric hypoxia, patent arterial duct and a new interventional technique to close it.
Freudenthal FP, Heath A, Villanueva J, et al. · Cardiol Young · 2012Research Support, Non-U.S. Gov't
- Use of a ductal occluder device as a test and then permanent closure of a large ductus arteriosus with increased pulmonary vascular resistance: a case report.
Fabiani N, Heath-Freudenthal A, Von Alvensleben I, et al. · Cardiol Young · 2025Case Reports
Other devices of this type
Also filed under product code MAE.
- Amplatzer Duct Occluder, Amplatzer Duct Occluder II, Amplatzer Piccolo OccluderAbbott Medical · PMA 2024
- Amplatzer Septal Occluder,cribriform Ocluder,and Delivery and Exchange SystemsAbbott Medical · PMA 2016
- Amplatzer Piccolo OccluderAbbott Medical · PMA 2023
- Pma Nit-Occlud PdaPfm Medical, Inc. · PMA 2016
- Amplatzer Septal Defect OccluderAbbott Medical · PMA 2015
- Amplatzer Multi-Fenestrated Septal Occluder ? ?cribriform? OccluderAbbott Medical · PMA 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.